Methicillin-resistantStaphylococcus aureusnosocomial pneumonia patients treated with ceftaroline: retrospective case series of 10 patients

Efficacy of Ceftaroline Fosamil in a Staphylococcal Murine Pneumonia Model

(2012) Amira A. Bhalodi et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In Vitro Activity of Ceftaroline Against Multidrug-Resistant Staphylococcus aureus and Streptococcus pneumoniae: A Review of Published Studies and the AWARE Surveillance Program (2008–2010)

(2012) David J. Farrell et al.   CLINICAL INFECTIOUS DISEASES

The Clinical Significance of Vancomycin Minimum Inhibitory Concentration in Staphylococcus aureus Infections: A Systematic Review and Meta-analysis

(2012) S. J. van Hal et al.   CLINICAL INFECTIOUS DISEASES

Linezolid in Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia: A Randomized, Controlled Study

(2012) R. G. Wunderink et al.   CLINICAL INFECTIOUS DISEASES

Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children

(2011) Catherine Liu et al.   CLINICAL INFECTIOUS DISEASES

Expanded Clinical Presentation of Community-Acquired Methicillin-Resistant Staphylococcus aureus Pneumonia

(2010) L. Jason Lobo et al.   CHEST

Integrated Analysis of FOCUS 1 and FOCUS 2: Randomized, Doubled‐Blinded, Multicenter Phase 3 Trials of the Efficacy and Safety of Ceftaroline Fosamil versus Ceftriaxone in Patients with Community‐Acquired Pneumonia

(2010) Thomas M. File et al.   CLINICAL INFECTIOUS DISEASES

In vitro evaluation of ceftaroline alone and in combination with tobramycin against hospital-acquired meticillin-resistant Staphylococcus aureus (HA-MRSA) isolates

(2010) Céline Vidaillac et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Ceftaroline: A New Cephalosporin with Activity Against Resistant Gram-Positive Pathogens

(2010) Molly E Steed et al.   PHARMACOTHERAPY